share_log

10-Q: Q2 2024 Earnings Report

10-Q: Q2 2024 Earnings Report

10-Q:2024财年二季报
美股SEC公告 ·  08/19 08:07

Moomoo AI 已提取核心信息

FOXO Technologies Inc. (FOXO) reported financial results for the quarter ended June 30, 2024. The company saw an increase in net revenues to $35, up 40% from $25 in the same period last year, primarily due to the acquisition of Myrtle, a behavioral health services provider. Operating expenses decreased by 81% to $2,803, with significant reductions in research and development, management contingent share plan expenses, and selling, general and administrative expenses. The company's net loss improved by 81% to $3,668, compared to a net loss of $18,932 in the prior year. The improvement was attributed to the decrease in operating expenses and non-operating expenses. FOXO's liquidity position remains a concern, with a working capital deficit and total stockholders' deficit of $20,817 and $16,167, respectively. The company has taken steps...Show More
FOXO Technologies Inc. (FOXO) reported financial results for the quarter ended June 30, 2024. The company saw an increase in net revenues to $35, up 40% from $25 in the same period last year, primarily due to the acquisition of Myrtle, a behavioral health services provider. Operating expenses decreased by 81% to $2,803, with significant reductions in research and development, management contingent share plan expenses, and selling, general and administrative expenses. The company's net loss improved by 81% to $3,668, compared to a net loss of $18,932 in the prior year. The improvement was attributed to the decrease in operating expenses and non-operating expenses. FOXO's liquidity position remains a concern, with a working capital deficit and total stockholders' deficit of $20,817 and $16,167, respectively. The company has taken steps to address its capital needs, including entering into stock exchange agreements with RHI to acquire Myrtle and RCHI, a critical care hospital, which are expected to provide positive operating cash flows. However, there is substantial doubt about FOXO's ability to continue as a going concern without securing additional financing. The company's future plans include continuing capital raise initiatives, pursuing strategic acquisitions, and commercializing products to generate revenue.
FOXO技术公司(FOXO)公布了2024年6月30日结束的季度财务报告。该公司的净收入上升至35美元,比去年同期的25美元增长了40%,这主要是由于收购了行为健康服务提供商Myrtle而导致的。营业费用下降了81%至2,803美元,研发、管理和销售一般管理费用大幅减少。净亏损从上年的18,932美元减少了81%至3,668美元。这一改善归因于营业费用和非营业费用的减少。FOXO的流动性仍然是一个问题,其营运资本亏损和总股东亏损分别为20,817美元和16,167美元。公司已经采取了措施来解决其资本需求,包括与RHI订立股票交易协议以收购Myrtle和一家关键护理医院RCHI,预计将提供正面的营运现金流。然而,FOXO能否在未获得额外融资的情况下继续作为一个持续发展的公司存在存在重大疑虑。该公司未来的计划包括继续资本筹集举措,追求战略性收购,并推广产品以产生收入。
FOXO技术公司(FOXO)公布了2024年6月30日结束的季度财务报告。该公司的净收入上升至35美元,比去年同期的25美元增长了40%,这主要是由于收购了行为健康服务提供商Myrtle而导致的。营业费用下降了81%至2,803美元,研发、管理和销售一般管理费用大幅减少。净亏损从上年的18,932美元减少了81%至3,668美元。这一改善归因于营业费用和非营业费用的减少。FOXO的流动性仍然是一个问题,其营运资本亏损和总股东亏损分别为20,817美元和16,167美元。公司已经采取了措施来解决其资本需求,包括与RHI订立股票交易协议以收购Myrtle和一家关键护理医院RCHI,预计将提供正面的营运现金流。然而,FOXO能否在未获得额外融资的情况下继续作为一个持续发展的公司存在存在重大疑虑。该公司未来的计划包括继续资本筹集举措,追求战略性收购,并推广产品以产生收入。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息